Intervention to Hepatic and Pulmonary Metastasis in Breast Cancer Patients (IMET)
Intervention to Hepatic and Pulmonary Metastasis in Breast Cancer Patients: Prospective, Observational, Multi-institutional Registration Study - IMET
Sponsor: Federation of Breast Diseases Societies
This observational or N/A phase trial investigates Breast Cancer and Metastasis and is currently ongoing. Federation of Breast Diseases Societies leads this study, which shows 10 recorded versions since 2014 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Sep 2024 — Sep 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jul 2022 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jan 2021 — Jul 2022 [monthly]
Recruiting
▶ Show 5 earlier versions
-
Mar 2020 — Jan 2021 [monthly]
Recruiting
-
Aug 2019 — Mar 2020 [monthly]
Recruiting
-
Jun 2018 — Aug 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Jun 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Federation of Breast Diseases Societies
For direct contact, visit the study record on ClinicalTrials.gov .